Personalized Medicine Partners, LLC
Personalized Medicine Partners, LLC (“PMP”), established in 2004, is dedicated to increasing the value of therapeutic and diagnostic products, technologies & services through integrated product and business development. We create this value through assessment, research and strategic planning followed by implementation activities that accelerate clinical development, differentiate products from their competition, generate market expansion and deliver sales growth.
We offer our services on a project basis or as part-time contract executive roles in pharmaceuticals and molecular diagnostics to deliver (1.) business and corporate development support throughout the transaction continuum from opportunity identification through deal execution and (2.) product development and C-level leadership support by optimizing treatment research, discovery, development and commercialization. Through our service, molecular data from the application of biomarker/diagnostic testing is transformed into knowledge, enabling more individualized patient care or personalized medicine. This approach to establishing clinical utility has demonstrated value for both treatments as well as personalized medicine tests, showing potential to improve health economic outcomes in diseases such as cancer and infectious diseases.
Michael Stocum, the firm’s President and founder has experience with multiple therapeutic areas and development of therapeutics and molecular diagnostics. His access to partners from other firms provides a breadth of experience to support the needs of most product development and commercialization programs. Please contact us for further information.